Evidence map›Paper›PMID 33692361›Full record

ArticleNature communications2021

Missense mutation of Fmr1 results in impaired AMPAR-mediated plasticity and socio-cognitive deficits in mice.

Marta Prieto, Alessandra Folci, Gwénola Poupon, Sara Schiavi, Valeria Buzzelli, Marie Pronot, Urielle François, Paula Pousinha, Norma Lattuada, Sophie Abelanet and 11 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
5.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. FMRP Sustains Presynaptic Function via Control of Activity-Dependent Bulk Endocytosis.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2022
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 3 institutions in 2 countries.

Marta Prieto *Université Côte d'Azur, CNRS, IPMC, Valbonne, France.
Alessandra Folci *Université Côte d'Azur, CNRS, IPMC, Valbonne, France.
Gwénola PouponUniversité Côte d'Azur, CNRS, IPMC, Valbonne, France.
Sara SchiaviRomaTre University, Dept. Science, Rome, Italy.
Valeria BuzzelliRomaTre University, Dept. Science, Rome, Italy.
Marie PronotUniversité Côte d'Azur, CNRS, IPMC, Valbonne, France.
Urielle FrançoisUniversity of Bordeaux, CNRS, IINS, Bordeaux, France.ORCID 0000-0001-9523-7542
Paula PousinhaUniversité Côte d'Azur, CNRS, IPMC, Valbonne, France.
Norma LattuadaUniversità degli Studi di Milano, Dept. of Medical Biotechnology and Translational Medicine, Milan, Italy.
Sophie AbelanetUniversité Côte d'Azur, CNRS, IPMC, Valbonne, France.
Sara CastagnolaUniversité Côte d'Azur, CNRS, IPMC, Valbonne, France.
Magda ChafaiUniversité Côte d'Azur, CNRS, IPMC, Valbonne, France.
Anouar KhayachiUniversité Côte d'Azur, CNRS, IPMC, Valbonne, France.
Carole GwizdekUniversité Côte d'Azur, CNRS, IPMC, Valbonne, France.
Frédéric BrauUniversité Côte d'Azur, CNRS, IPMC, Valbonne, France.
Emmanuel DevalUniversité Côte d'Azur, CNRS, IPMC, Valbonne, France.
Maura FrancoliniUniversità degli Studi di Milano, Dept. of Medical Biotechnology and Translational Medicine, Milan, Italy.
Barbara BardoniUniversité Côte d'Azur, Inserm, CNRS, IPMC, Valbonne, France.ORCID 0000-0001-6411-1517
Yann HumeauUniversity of Bordeaux, CNRS, IINS, Bordeaux, France.ORCID 0000-0003-0471-3414
Viviana TrezzaRomaTre University, Dept. Science, Rome, Italy.
Stéphane MartinUniversité Côte d'Azur, Inserm, CNRS, IPMC, Valbonne, France. martin@ipmc.cnrs.fr.ORCID 0000-0001-6771-7645
Centre National de la Recherche Scientifique · FRRoma Tre University · ITUniversity of Milan · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Fragile X syndrome (FXS) is the most frequent form of inherited intellectual disability and the best-described monogenic cause of autism. CGG-repeat expansion in the FMR1 gene leads to FMR1 silencing, loss-of-expression of the Fragile X Mental Retardation Protein (FMRP), and is a common cause of FXS. Missense mutations in the FMR1 gene were also identified in FXS patients, including the recurrent FMRP-R138Q mutation. To investigate the mechanisms underlying FXS caused by this mutation, we generated a knock-in mouse model (Fmr1

Indexed as

AnimalsBiotinylationBrainCells, CulturedCognitive DysfunctionFemaleFragile X Messenger Ribonucleoprotein 1HippocampusHumansImmunoblottingLong-Term PotentiationMaleMiceMutation, MissensePatch-Clamp TechniquesReceptors, GlutamateFmr1 protein, mouseFragile X Messenger Ribonucleoprotein 1Receptors, Glutamate

Identifiers

PMID33692361
PMCPMC7946954
OpenAlexW3135810105

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.